ClinicalTrials.gg
RecruitingNCT00898131Updated Oct 20, 2025

Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer

An observational study in Breast Cancer, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to female participants. Per ClinicalTrials.gov, last updated 2025-10-20.

Sponsored by Northwestern University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10,000
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Breast Neoplasms by Northwestern University — 4 open to participants now, 6 under way, 1 of them phase 3. Breast Neoplasms · Northwestern University.

Started
2001
with 1 other
Observational
7 of 64
1 open now
Registered
22nd of 64
by date

Among the 64 studies in Breast Neoplasms by Northwestern University, this one is one of 2 that started in 2001, is one of 7 observational ones, and was the 22nd registered.

Breast Neoplasms

14,855 studies on the registry are indexed under Breast Neoplasms; 3,321 are open to participants now.

Browse Breast Neoplasms studies →

Open to participants now

4 of the 64 studies in Breast Neoplasms by Northwestern University are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 2,403 Breast Neoplasms studies recruiting now, 1,574 (66%) set no upper age limit and 591 (25%) stop at 75 or younger; 103 take children under 18; 215 take healthy volunteers.

This study: female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Breast Neoplasms by Northwestern University, or all of them as a file.
02

Study summary

RATIONALE: Collecting and storing samples of tumor tissue from patients with breast cancer to study in the laboratory may help doctors learn more about cancer.

PURPOSE: This phase I study is collecting tissue samples for future research from women undergoing surgery for breast cancer.

Read the detailed description

OBJECTIVES:

Primary

  • Collect breast tissue for future research from women undergoing surgery for breast cancer.

Secondary

  • Create microarrays by tumor type for internal use by Specialized Program of Research Excellence.

OUTLINE: Tumor tissue is collected and analyzed to create microarrays by tumor type for future research studies.

PROJECTED ACCRUAL: A total of 1,250 patients will be accrued for this study.

03

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • breast cancer
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women undergoing biopsy or surgical procedures for the diagnosis, treatment, or prevention of breast cancer.

Eligibility criteria

DISEASE CHARACTERISTICS:

  • Undergoing surgery for breast cancer
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Collect human breast tissues and associated clinical-pathologic data

    Time frame: At time of diagnosis, surgery, and throughout standard care and clinical follow-up.

07

Study locations

1 of 1 sites recruiting
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Chicago, Illinois 60611-3013, United States
    Recruiting
    • Clinical Trials Office - Robert H. Lurie Comprehensive Cancer · Contactcancer@northwestern.edu · 312-695-1301
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2001, a primary completion of Jan 2026 and a completion of Jan 2026. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 9, 2009
First posted
May 12, 2009
Start
Aug 2001
Primary completionEst.
Jan 2026
CompletionEst.
Jan 2026
Last update
Oct 20, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00898131
Responsible party
Sponsor
First posted
May 12, 2009
Start date
Aug 2001
Primary completion
Jan 2026 (estimated)
Completion
Jan 2026 (estimated)
Last update
Oct 20, 2025

Study contacts

Seema Khan, MD
Contact
cancertrials@northwestern.edu
312-695-1301
Piotr Kulesza, MD, PhD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion